⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Official Title: A Phase II Trial of Arsenic Trioxide (NSC #706363) for Relapsed or Refractory Acute Lymphoblastic Leukemia

Study ID: NCT00006008

Conditions

Leukemia

Interventions

arsenic trioxide

Study Description

Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have relapsed or refractory acute lymphoblastic leukemia.

Detailed Description: OBJECTIVES: * Determine the complete remission rate of patients with relapsed or refractory acute lymphoblastic leukemia treated with arsenic trioxide. * Determine the toxic effects of induction arsenic trioxide in this patient population. OUTLINE: Patients are stratified according to administration schedule of arsenic trioxide (5 days a week vs 7 days a week). Patients receive arsenic trioxide IV over 1 hour daily until bone marrow blasts are less than 5% or for a maximum of 60 days. Beginning 3-6 weeks after induction, patients achieving a complete remission receive arsenic trioxide IV over 1 hour daily either 5 days or 7 days a week for 25 days. Subsequent consolidation courses are given with 4 week treatment-free intervals between courses. Treatment continues for a maximum of 5 consolidation courses in the absence of unacceptable toxicity or disease progression. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter. PROJECTED ACCRUAL: A total of 13-40 patients will be accrued for this study within 3 years.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

Cancer Center and Beckman Research Institute, City of Hope, Duarte, California, United States

Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States

Stanford University Medical Center, Stanford, California, United States

CCOP - Colorado Cancer Research Program, Inc., Denver, Colorado, United States

CCOP - Christiana Care Health Services, Wilmington, Delaware, United States

Veterans Affairs Medical Center - Gainsville, Gainesville, Florida, United States

Veterans Affairs Medical Center - Miami, Miami, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Veterans Affairs Medical Center - Tampa (Haley), Tampa, Florida, United States

Emory University Hospital - Atlanta, Atlanta, Georgia, United States

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States

CCOP - Central Illinois, Decatur, Illinois, United States

CCOP - Evanston, Evanston, Illinois, United States

CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States

CCOP - Carle Cancer Center, Urbana, Illinois, United States

Indiana University Cancer Center, Indianapolis, Indiana, United States

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States

MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States

CCOP - Ochsner, New Orleans, Louisiana, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

New England Medical Center Hospital, Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States

CCOP - Kalamazoo, Kalamazoo, Michigan, United States

CCOP - Duluth, Duluth, Minnesota, United States

Veterans Affairs Medical Center - Minneapolis, Minneapolis, Minnesota, United States

University of Minnesota Cancer Center, Minneapolis, Minnesota, United States

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States

Veterans Affairs Medical Center - Omaha, Omaha, Nebraska, United States

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States

CCOP - Northern New Jersey, Hackensack, New Jersey, United States

Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States

Veterans Affairs Medical Center - Brooklyn, Brooklyn, New York, United States

Veterans Affairs Medical Center - New York, New York, New York, United States

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

CCOP - Merit Care Hospital, Fargo, North Dakota, United States

Ireland Cancer Center, Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

CCOP - Columbus, Columbus, Ohio, United States

CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States

CCOP - Oklahoma, Tulsa, Oklahoma, United States

CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States

Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

Veterans Affairs Medical Center - Pittsburgh, Pittsburgh, Pennsylvania, United States

CCOP - MainLine Health, Wynnewood, Pennsylvania, United States

CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States

Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Veterans Affairs Medical Center - Madison, Madison, Wisconsin, United States

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States

CCOP - Marshfield Medical Research and Education Foundation, Marshfield, Wisconsin, United States

Marshfield Clinic, Marshfield, Wisconsin, United States

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States

MBCCOP - San Juan, San Juan, , Puerto Rico

Veterans Affairs Medical Center - San Juan, San Juan, , Puerto Rico

Pretoria Academic Hospitals, Pretoria, , South Africa

Contact Details

Name: Mark R. Litzow, MD

Affiliation: Mayo Clinic

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: